Abdellaziz Dahou, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Valve Stenosis | 43 | 2024 | 2023 | 3.740 |
Why?
|
Aortic Valve | 29 | 2024 | 1968 | 2.400 |
Why?
|
Tricuspid Valve Insufficiency | 10 | 2023 | 363 | 2.240 |
Why?
|
Heart Valve Prosthesis Implantation | 24 | 2024 | 1566 | 2.130 |
Why?
|
Stroke Volume | 20 | 2024 | 5596 | 1.510 |
Why?
|
Tricuspid Valve | 6 | 2023 | 422 | 1.360 |
Why?
|
Heart Valve Prosthesis | 18 | 2024 | 1466 | 1.340 |
Why?
|
Echocardiography, Doppler | 18 | 2020 | 899 | 1.280 |
Why?
|
Ventricular Function, Left | 17 | 2022 | 3928 | 1.190 |
Why?
|
Hemodynamics | 13 | 2020 | 4184 | 1.140 |
Why?
|
Echocardiography, Stress | 5 | 2021 | 137 | 0.930 |
Why?
|
Aortic Valve Insufficiency | 8 | 2020 | 575 | 0.760 |
Why?
|
Bioprosthesis | 6 | 2020 | 589 | 0.580 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2015 | 68 | 0.480 |
Why?
|
Ventricular Function, Right | 1 | 2019 | 629 | 0.460 |
Why?
|
Calcinosis | 5 | 2020 | 1479 | 0.410 |
Why?
|
Troponin T | 1 | 2017 | 785 | 0.400 |
Why?
|
Severity of Illness Index | 25 | 2023 | 15880 | 0.380 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2017 | 1736 | 0.370 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2024 | 2136 | 0.340 |
Why?
|
Prosthesis Design | 11 | 2024 | 2105 | 0.310 |
Why?
|
Cause of Death | 3 | 2017 | 3708 | 0.310 |
Why?
|
Prospective Studies | 28 | 2024 | 54802 | 0.310 |
Why?
|
Aged, 80 and over | 33 | 2024 | 59489 | 0.310 |
Why?
|
Prosthesis Failure | 5 | 2020 | 1191 | 0.300 |
Why?
|
Arrhythmias, Cardiac | 1 | 2016 | 2247 | 0.270 |
Why?
|
Blood Flow Velocity | 2 | 2021 | 1381 | 0.260 |
Why?
|
Predictive Value of Tests | 11 | 2020 | 15398 | 0.250 |
Why?
|
Mitral Valve Insufficiency | 4 | 2020 | 1414 | 0.250 |
Why?
|
Patient Selection | 3 | 2018 | 4255 | 0.240 |
Why?
|
Aged | 48 | 2024 | 171117 | 0.240 |
Why?
|
Registries | 9 | 2024 | 8297 | 0.240 |
Why?
|
Echocardiography | 8 | 2024 | 5045 | 0.230 |
Why?
|
Lipoproteins, LDL | 2 | 2017 | 643 | 0.220 |
Why?
|
Proportional Hazards Models | 10 | 2020 | 12509 | 0.220 |
Why?
|
Time Factors | 18 | 2021 | 40065 | 0.210 |
Why?
|
Heart Injuries | 2 | 2015 | 206 | 0.210 |
Why?
|
Risk Assessment | 14 | 2024 | 24282 | 0.200 |
Why?
|
Quebec | 3 | 2017 | 140 | 0.200 |
Why?
|
Treatment Outcome | 26 | 2024 | 65188 | 0.190 |
Why?
|
Prognosis | 12 | 2022 | 29922 | 0.190 |
Why?
|
Ventricular Remodeling | 3 | 2021 | 1272 | 0.190 |
Why?
|
Dobutamine | 1 | 2021 | 114 | 0.190 |
Why?
|
Risk Factors | 18 | 2021 | 74840 | 0.180 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2021 | 52 | 0.180 |
Why?
|
Male | 51 | 2024 | 363698 | 0.170 |
Why?
|
Mitral Valve | 2 | 2020 | 1476 | 0.170 |
Why?
|
Female | 50 | 2024 | 396112 | 0.160 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2018 | 127 | 0.160 |
Why?
|
Chi-Square Distribution | 5 | 2016 | 3432 | 0.160 |
Why?
|
Phosphoric Diester Hydrolases | 2 | 2019 | 204 | 0.150 |
Why?
|
Postoperative Complications | 8 | 2024 | 15747 | 0.150 |
Why?
|
Ventricular Dysfunction | 1 | 2019 | 143 | 0.150 |
Why?
|
Humans | 61 | 2024 | 765968 | 0.150 |
Why?
|
Asymptomatic Diseases | 2 | 2018 | 586 | 0.150 |
Why?
|
Patient Readmission | 4 | 2020 | 3286 | 0.140 |
Why?
|
Endovascular Procedures | 2 | 2021 | 2222 | 0.140 |
Why?
|
Vinca Alkaloids | 1 | 2016 | 36 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 6 | 2017 | 6499 | 0.130 |
Why?
|
Femoral Artery | 1 | 2020 | 811 | 0.130 |
Why?
|
Hypertension, Pulmonary | 2 | 2019 | 1604 | 0.130 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2017 | 234 | 0.130 |
Why?
|
Compliance | 1 | 2016 | 100 | 0.130 |
Why?
|
Magnetic Resonance Imaging, Cine | 3 | 2022 | 1094 | 0.130 |
Why?
|
Follow-Up Studies | 12 | 2021 | 39193 | 0.120 |
Why?
|
Multivariate Analysis | 7 | 2016 | 12056 | 0.120 |
Why?
|
Viscera | 1 | 2014 | 137 | 0.110 |
Why?
|
Recovery of Function | 3 | 2020 | 2966 | 0.110 |
Why?
|
Heart Failure | 5 | 2023 | 11840 | 0.100 |
Why?
|
Systole | 3 | 2024 | 935 | 0.100 |
Why?
|
Pulmonary Artery | 2 | 2019 | 1935 | 0.100 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2017 | 855 | 0.100 |
Why?
|
Osteogenesis | 1 | 2019 | 1282 | 0.100 |
Why?
|
Middle Aged | 17 | 2018 | 223009 | 0.100 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 674 | 0.100 |
Why?
|
Arteries | 1 | 2016 | 1118 | 0.090 |
Why?
|
Lipoprotein(a) | 1 | 2015 | 488 | 0.090 |
Why?
|
Folic Acid | 1 | 2016 | 1338 | 0.080 |
Why?
|
Protein Precursors | 1 | 2013 | 1134 | 0.080 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2015 | 645 | 0.080 |
Why?
|
NF-kappa B | 1 | 2017 | 2485 | 0.080 |
Why?
|
Blood Platelets | 1 | 2019 | 2464 | 0.080 |
Why?
|
Disease Progression | 4 | 2020 | 13632 | 0.070 |
Why?
|
Down-Regulation | 1 | 2015 | 2927 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1880 | 0.070 |
Why?
|
Survival Analysis | 2 | 2020 | 10070 | 0.070 |
Why?
|
North America | 2 | 2020 | 1285 | 0.070 |
Why?
|
Logistic Models | 3 | 2016 | 13266 | 0.070 |
Why?
|
Mortality | 1 | 2017 | 2904 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2022 | 5302 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2016 | 1434 | 0.060 |
Why?
|
Heart Ventricles | 2 | 2019 | 3832 | 0.060 |
Why?
|
Lysophospholipids | 2 | 2019 | 335 | 0.060 |
Why?
|
Comorbidity | 2 | 2016 | 10563 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2018 | 5343 | 0.060 |
Why?
|
Prosthesis Fitting | 1 | 2024 | 74 | 0.050 |
Why?
|
Retrospective Studies | 11 | 2021 | 81514 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20124 | 0.050 |
Why?
|
Canada | 2 | 2018 | 2119 | 0.050 |
Why?
|
Myocardium | 1 | 2015 | 4760 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2014 | 3312 | 0.050 |
Why?
|
Linear Models | 3 | 2016 | 5876 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2013 | 5125 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5937 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2022 | 3672 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 2 | 2018 | 1093 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18293 | 0.040 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2019 | 51 | 0.040 |
Why?
|
MicroRNAs | 1 | 2015 | 3785 | 0.040 |
Why?
|
Integrin beta3 | 1 | 2019 | 120 | 0.040 |
Why?
|
Apolipoprotein B-100 | 1 | 2019 | 157 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2021 | 538 | 0.040 |
Why?
|
ROC Curve | 2 | 2016 | 3620 | 0.040 |
Why?
|
Gadolinium | 1 | 2022 | 965 | 0.040 |
Why?
|
Survival Rate | 3 | 2017 | 12795 | 0.040 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2017 | 78 | 0.040 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2019 | 939 | 0.030 |
Why?
|
Surgical Instruments | 1 | 2019 | 377 | 0.030 |
Why?
|
Quality of Life | 3 | 2023 | 13462 | 0.030 |
Why?
|
Preoperative Period | 1 | 2018 | 566 | 0.030 |
Why?
|
Hypertension | 1 | 2016 | 8626 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2475 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2019 | 1884 | 0.030 |
Why?
|
Cohort Studies | 4 | 2020 | 41649 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10603 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2017 | 586 | 0.030 |
Why?
|
Creatine Kinase | 1 | 2015 | 682 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2014 | 353 | 0.030 |
Why?
|
Angiography | 1 | 2018 | 1581 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1638 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2019 | 18973 | 0.020 |
Why?
|
Troponin | 1 | 2015 | 533 | 0.020 |
Why?
|
Diastole | 1 | 2013 | 785 | 0.020 |
Why?
|
Rats | 2 | 2019 | 23707 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2260 | 0.020 |
Why?
|
Subcutaneous Fat | 1 | 2014 | 402 | 0.020 |
Why?
|
Contrast Media | 1 | 2022 | 5329 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3222 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2018 | 2393 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6493 | 0.020 |
Why?
|
Animals | 5 | 2019 | 168764 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1968 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2615 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20659 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4294 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36532 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2014 | 1426 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 21480 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6203 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6832 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8278 | 0.020 |
Why?
|
Mice | 3 | 2019 | 81819 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2015 | 2186 | 0.020 |
Why?
|
Macrophages | 1 | 2019 | 5772 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2015 | 8102 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9649 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2017 | 3675 | 0.010 |
Why?
|
Heart | 1 | 2015 | 4414 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14751 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18380 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14448 | 0.010 |
Why?
|
Stroke | 1 | 2020 | 9747 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22223 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15842 | 0.010 |
Why?
|
Hospitalization | 1 | 2017 | 10808 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2015 | 22332 | 0.010 |
Why?
|
Body Mass Index | 1 | 2014 | 13039 | 0.010 |
Why?
|
Algorithms | 1 | 2016 | 14071 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10850 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26318 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23601 | 0.010 |
Why?
|
United States | 1 | 2017 | 72903 | 0.010 |
Why?
|
Adult | 1 | 2015 | 223044 | 0.000 |
Why?
|